RBD and Neurodegenerative Diseases (Q38794700)

6 September 2017

title

RBD and Neurodegenerative Diseases (English)

1 reference

6 September 2017

1 reference

Haiyang Jiang

1 reference

6 September 2017

Jinsha Huang

1 reference

6 September 2017

Yan Shen

1 reference

6 September 2017

Shiyi Guo

1 reference

6 September 2017

Luxi Wang

1 reference

6 September 2017

Chao Han

1 reference

6 September 2017

Ling Liu

1 reference

6 September 2017

Kai Ma

1 reference

6 September 2017

Yun Xia

1 reference

6 September 2017

Jie Li

1 reference

6 September 2017

Xiaoyun Xu

1 reference

6 September 2017

Nian Xiong

1 reference

6 September 2017

Tao Wang

1 reference

6 September 2017

publication date

31 March 2016

1 reference

6 September 2017

published in

Molecular Neurobiology

1 reference

6 September 2017

1 reference

6 September 2017

1 reference

6 September 2017

page(s)

2997-3006

1 reference

Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

REM sleep behavior disorder and motor dysfunction in Parkinson's disease--a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Changing demographics in REM sleep behavior disorder: possible effect of autoimmunity and antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

REM sleep behaviour disorder (RBD) and its associations in young patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Characteristics of early- and late-onset rapid eye movement sleep behavior disorder in China: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Gender differences in REM sleep behavior disorder: a clinical and polysomnographic study in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Idiopathic rapid-eye-movement sleep disorder: associations with antidepressants, psychiatric diagnoses, and other factors, in relation to age of onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Rapid eye movement sleep behavior disorder in adults younger than 50 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

REM sleep behavior disorder and REM sleep without atonia as an early manifestation of degenerative neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Neurophysiological insights into the pathophysiology of REM sleep behavior disorders: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Severe obstructive sleep apnea/hypopnea mimicking REM sleep behavior disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

REM sleep behavior disorder: Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

A putative flip-flop switch for control of REM sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Control of sleep and wakefulness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

The stuff dreams are made of: anatomical substrates of REM sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

REM sleep behavior disorder: motor manifestations and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Medullary circuitry regulating rapid eye movement sleep and motor atonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Breakdown in REM sleep circuitry underlies REM sleep behavior disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Importance of the ventrolateral region of the periaqueductal gray and adjacent tegmentum in the control of paradoxical sleep as studied by muscimol microinjections in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

REM sleep behavior disorder in a patient with pontine stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

A brainstem inflammatory lesion causing REM sleep behavior disorder and sleepwalking (parasomnia overlap disorder).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Reduced volume of the putamen in REM sleep behavior disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Serotonergic antidepressants are associated with REM sleep without atonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Behavioral correlates of activity in identified hypocretin/orexin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Relationship between CSF hypocretin levels and hypocretin neuronal loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Reduced number of hypocretin neurons in human narcolepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Hypocretin (orexin) cell loss in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Hypocretin (orexin) loss in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

CSF hypocretin/orexin levels in narcolepsy and other neurological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Low level of ventricular CSF orexin-A is not associated with objective sleepiness in PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Parkinson's disease comorbid with narcolepsy presenting low CSF hypocretin/orexin level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Involvement of hypocretin neurons in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

CSF hypocretin-1 levels are normal in multiple-system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Reduced hypocretin (orexin) levels in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Neuropathological investigation of hypocretin expression in brains of dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

In Alzheimer disease, increased wake fragmentation found in those with lower hypocretin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Orexin loss in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

REM sleep behavior disorder in the Korean elderly population: prevalence and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Rapid eye movement sleep behavior disorder as a biomarker for neurodegeneration: the past 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Does idiopathic REM sleep behavior disorder (iRBD) really exist? What are the potential markers of neurodegeneration in iRBD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

REM sleep behaviour disorder in Parkinson's disease is associated with specific motor features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Relation between subtype of Parkinson's disease and REM sleep behavior disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Associated factors for REM sleep behavior disorder in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Rapid eye movement sleep behavioral events: a new marker for neurodegeneration in early Parkinson disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

The timing between REM sleep behavior disorder and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Clinical manifestations of Parkinson disease and the onset of rapid eye movement sleep behavior disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

REM sleep behavior disorder: association with motor complications and impulse control disorders in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Parkinson's disease and REM sleep behavior disorder result in increased non-motor symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Revisiting the impact of REM sleep behavior disorder on motor progression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

REM behaviour disorder and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

REM sleep behavior disorders in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Sleep Disorders in Atypical Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

REM sleep behaviour disorder: how useful is it for the differential diagnosis of parkinsonism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Cognitive and sleep features of multiple system atrophy: review and prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Cognition in rapid eye movement sleep behavior disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Prevalence of REM sleep behavior disorder in multiple system atrophy: a multicenter study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Comparison of the clinical features of rapid eye movement sleep behavior disorder in patients with Parkinson's disease and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

No Difference in Sleep and RBD between Different Types of Patients with Multiple System Atrophy: A Pilot Video-Polysomnographical Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

REM sleep behaviour disorder differentiates pure autonomic failure from multiple system atrophy with autonomic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

REM sleep behavioral disorder in pure autonomic failure (PAF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Analysis of video-polysomnographic sleep findings in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Effect of genetically caused excess of brain gamma-hydroxybutyric acid and GABA on sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Spinal and Bulbar Muscular Atrophy Overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Rapid eye movement sleep disturbances in Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Nocturnal agitation in Huntington disease is caused by arousal-related abnormal movements rather than by rapid eye movement sleep behavior disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Polysomnographic Findings and Clinical Correlates in Huntington Disease: A Cross-Sectional Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Presumed rapid eye movement behavior disorder in Machado-Joseph disease (spinocerebellar ataxia type 3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

REM behavior disorder and excessive daytime somnolence in Machado-Joseph disease (SCA-3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

REM sleep behavior disorder and vocal cord paralysis in Machado‐Joseph disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

Use of ramelteon for the treatment of secondary REM sleep behavior disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-9831-4

[THE STUDY OF THE OCULAR MOTOR ACTIVITY DURING THE PARADOXICAL PHASE OF SLEEP IN THE CAT]

21 January 2018

1 reference

12 December 2020

Normal hypocretin-1 levels in Parkinson's disease patients with excessive daytime sleepiness

1 reference

12 December 2020

The rat ponto-medullary network responsible for paradoxical sleep onset and maintenance: a combined microinjection and functional neuroanatomical study

1 reference

12 December 2020

Altered CSF orexin and α-synuclein levels in dementia patients

1 reference

12 December 2020

1 reference

12 December 2020

Sleep and breathing in multiple system atrophy

1 reference

12 December 2020

REM sleep behavior disorder in Parkinson's disease: a questionnaire-based survey

1 reference

12 December 2020

Dementia with Lewy bodies

1 reference

12 December 2020

Best practice guide for the treatment of REM sleep behavior disorder (RBD).

1 reference

12 December 2020

Neurons containing hypocretin (orexin) project to multiple neuronal systems

1 reference

12 December 2020

Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus.

1 reference

12 December 2020

Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic

1 reference

12 December 2020

Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy

1 reference

12 December 2020

From pathways to targets: understanding the mechanisms behind polyglutamine disease.

1 reference

12 December 2020

Clinical implication of REM sleep behavior disorder in Parkinson's disease

1 reference

12 December 2020

Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons.

1 reference

12 December 2020

REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy.

1 reference

12 December 2020

REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study

1 reference

12 December 2020

Medullary regions mediating atonia

1 reference

12 December 2020

10.1007/S12035-016-9831-4

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1026176979

0 references

1 reference